Ibalizumab-uiyk as a bridge therapy for a patient with drug-resistant HIV-1 infection receiving chemotherapy: A case report.

Jana K DickterAbigail L MartinStephanie HoJustine Abella RossGeoffrey P Shouse

Published in: Journal of clinical pharmacy and therapeutics (2021)

Ibalizumab-uiyk has no known drug-drug interactions and may be used as bridge therapy for patients with drug-resistant HIV undergoing chemotherapy.

Keyphrases